eMERGE is a national network organized and funded by the National Human Genome Research Institute (NHGRI) that combines DNA biorepositories with electronic medical record (EMR) systems for large scale, high-throughput genetic research in support of implementing genomic medicine.
Many factors contribute to risk of a disease. Some of these factors are internal, like genetics, and others are external, like where someone lives. Over the last several years researchers have discovered that in addition to one gene being associated with a given disease (monogenic factors), many genes across your genome can contribute to the development of a disease (polygenic factors). To learn more about elements that contribute to risk a disease, click here.
NHGRI announces the next round of the eMERGE Network
July 7, 2020 2:19 PM
Publication Update: MCS NT304 published in the American Journal of Human Genetics
May 5, 2020 1:09 PM
eMERGE Network: RFA Publications
March 3, 2020 1:50 PM
Notice to active NHGRI research grant awardees
February 2, 2020 8:03 PM
Notice of Special Interest
January 1, 2020 7:22 PM
NHGRI Recruitment for Scientific Program Analysts
November 11, 2019 1:38 PM
Pathak GA, Singh K, Miller-Fleming TW, Wendt F, Mancuso N, et al. Integrative analyses identify susceptibility genes underlying COVID-19 hospitalization. medRxiv : the preprint server for health sciences. 2020 Dec 8;.
Kullo IJ. Familial Hypercholesterolemia: A Reportable Disorder. Circulation. 2020 Nov 24;142(21):1999-2001.
Chang X, Liu Y, Mentch F, Glessner J, Hakonarson H. Mitochondrial DNA haplogroups and risk of attention deficit and hyperactivity disorder in European Americans. Translational psychiatry. 2020 Nov 2;10(1):370.